Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.36

-1.11

-0.85

-0.6

Details

Expected EPS

-0.84107

Actual EPS

-0.6

Surprise EPS

0.24

Surprise Percent

+28.66%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.6 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.